key: cord-0908588-ec3367s0
authors: Sandhu, Simrenjeet; Liu, Daisy; Mathura, Pamela; Palakkamanil, Mathew; Kurji, Khaliq; Rudnisky, Christopher J.; Kassiri, Kam
title: Immediately Sequential Bilateral Cataract Surgery (ISBCS) Adapted Protocol during Covid 19: quality improvement initiative
date: 2021-11-09
journal: Can J Ophthalmol
DOI: 10.1016/j.jcjo.2021.10.003
sha: e2a89b9cbfd09821691e7a0e410c80f599072d79
doc_id: 908588
cord_uid: ec3367s0

Objective To describe the steps, hurdles, and recommendations for the implementation of ISBCS evidence-based protocol at a high-volume Canadian tertiary care centre. Design Quality improvement study Participants A total of 406 patients who underwent ISBCS from July 2020 to December 2020. Patients were selected based on specific inclusion and exclusion criteria including psychosocial factors, refractive error and consent. This initiative impacted staff at all levels involved with cataract surgery. Methods The Model of Improvement framework was used and involved numerous discussions with multidisciplinary teams of ophthalmologists, nursing and support staff, management, pharmacists, and medical device reprocessing teams. This initiative was created and refined via a thorough review of the literature and current best practices. It was implemented in July 2020 after a nursing “huddle”. Any adverse outcomes and overall impact were collected from various levels of staff involved. Results Each eye was treated as a separate surgery with a “double time out” per bilateral case. Additional measures were taken to ensure different lot numbers for medications, equipment and materials. This practice increased surgical volume approximately by 25% and reduced the number of patient visits by 50%, reducing potential COVID-19 exposure. Conclusions The resulting protocol from our study may be useful to other centres wishing to integrate ISBCS, as one example of successful implementation. Of the 406 cases of ISBCS performed, we report zero cases of TASS or endophthalmitis. In times of decreased elective surgeries, ISBCS is a safe and effective option to supplement surgical volume and provide significant patient benefits.

Because of the Coronavirus disease 2019 (COVID-19) pandemic response, elective surgery in Canada has drastically decreased, resulting in markedly increased waitlists. An average of 75.5 days across all provinces were lost to perform procedures in the spring of 2020 alone. 1 With patients previously waiting many months (up to 219 days in 2019) 2 for cataract surgery in an already backlogged healthcare system, it is critical to provide timely care to patients, despite these new challenges, while also providing high quality outcomes.

Immediately sequential bilateral cataract surgery (ISBCS) has been debated since the inception of cataract surgery. Though not accepted as the standard of care due to complications at the time, 3 there are numerous well-documented benefits to ISBCS. In the last decade there has been a growing body of literature, including several randomized controlled trials, demonstrating the safety and efficacy of ISBCS. [4] [5] [6] ISBCS is also becoming a common practice globally, particularly in countries that do not financially penalize for simultaneous surgery; in Finland and Sweden, 40% of all cases are ISBCS. [7] [8] [9] In 2006, 80% of all cases in the Canary Islands were ISBCS and found to be equally as safe and efficient as DSBCS (delayed sequential bilateral cataract surgery), 10 which is the current standard of practice in North America.

Global ISBCS statistics are not yet available for the United States and Canada. However ISBCS is emerging as a primary consideration for eligible patients. For instance, Kaiser Permanente Health Maintenance Organization, the largest Health Maintenance Organization in the United States, reported on 3,561 ISBCS procedures (7,122 eyes). [11] [12] [13] Vision Group Canada reports over 30,000 ISBCS procedures, including bilateral refractive lens exchange, over the past decade performed by 50 surgeons. Dr. Steve Arshinoff based in Toronto, Canada has completed over 12,000 ISBCS procedures over the past 25 years, and currently performs ISBCS on 80-90% of patients. [8] [9] [10] [11] [12] [13] [14] Finally, Centre Universitaire d'Ophtalmologie due CHU de Québec-Université Laval reports over 6,500 ISBCS procedures (13,000 eyes) over 4 years, with resident participation, accounting for over 50% of all cataract procedures. 15 Notably, these groups have unanimously reported no cases of bilateral postoperative endophthalmitis or bilateral toxic anterior segment syndrome (TASS) while following the General Principles for Excellence in ISBCS established by the International Society of Bilateral Cataract Surgeons (iSBCS) in 2009. 16 Historically, the main barrier to general acceptance of ISBCS has been the possibility of developing these complications, which have severe consequences. With the introduction of intracameral antibiotics including cephalosporins, vancomycin and fluroquinolones, of which moxifloxacin is the most common, these risks have been reduced considerably. 17 Growing literature supporting the safety and efficacy of ISBCS combined with the unique challenges of the COVID-19 pandemic have led the Department of Ophthalmology at the University of Alberta in Edmonton, Canada to adopt new standards of practice for cataract surgery.

In April 2020, the challenge faced was that cataract suites were operating at 0% capacity. 1 By May and June 2020, ophthalmologists gradually returned to operating rooms with an immense backlog of thousands of cataract surgeries, but were restricted to 50% capacity. Consequently, the Department of Ophthalmology reviewed the current CPSBC guidelines and consulted CMPA regarding medicolegal considerations of ISBCS. This quality improvement (QI) study will discuss the steps undertaken to adapt, create and implement our ISBCS guidelines/process initiative at our hospital-based surgical center. Candidacy including indications and contraindications for our ISBCS initiative will be reviewed, challenges and potential solutions will be outlined. We will also discuss major complications that have occurred since the implementation of ISBCS at our center.

A multidisciplinary study team was assembled and included ophthalmologists, nursing staff, management, pharmacists, suppliers and staff in medical device reprocessing team, to develop the proposed ISBCS initiative (Fig. 1) . Utilizing stakeholder concerns, and frontline perspectives, a literature review of best practices and other institutions' experiences, and a new ISBCS guidelines was established.

The Model for Improvement framework guided this QI project, which involved plan-do-studyact (PDSA) cycles, allowing for continuous innovation, evaluation and improvement. 25 The aim of this QI study was to review and adapt the ISBCS best practices, address stakeholder concerns and obtain frontline perspectives to better utilize operating room time during the COVID-19 pandemic. The QI project goal was to complete 5 ISBCS cases per day per surgeon per surgical day increasing the daily cataract volume per surgeon in 6 months. The rationale for selecting 5 cases per day were based on the number of surgeons, past procedure time history, the allocated OR time and number of patients on the waitlist. The Donabedian conceptual evaluation framework was employed to evaluate the intervention through a set of measures, including process, outcome and balancing measures. 26 The process measures were: number of ISBCS completed per day per surgeon using the adapted guideline intervention. The outcome measures were: reduction of cataract surgical waitlist, optimization of OR time and decreased visits to the clinic and hospitals. Balancing measures indicate unintended adverse events which was the number of TASS or endophthalmitis.

The new ISBCS guidelines was initially trialed starting July 2020. The first cycle of improvement was for 1 month, followed by a formal QI team debrief, where slight modifications were made regarding nursing role and responsibility. During daily nursing huddles all staff members were informed of the change and encouraged to prospectively report adverse events, process impacts and to offer comments and suggestions regarding the initiative. This daily feedback was verbally given to the managers of the operating room. Subsequently, every month our QI team met to formally debrief to ensure where appropriate continuous guideline adjustments were made by the study team and communicated to all staff. All adverse events were reported, tracked and followed up by the retina team. During these meetings, patient inclusion criteria, consent guidelines, intraoperative guidelines, postoperative considerations were developed. We also collected real-time nursing feedback to make swift adjustments to support protocol implementation. Additionally, nursing feedback suggested all ISBCS be booked after 09:00, when full nursing capacity would be available. Also, it was recommended that the order to which eyes undergoing ISBCS be standardized, always starting with the left eye and then finishing with the right eye to further streamline the process. Historically, the majority of surgeons were right-handed, therefore completing the left eye first can be helpful in avoiding it while working on the right eye. Standardizing this way can also reduce human error as well as improving efficiency. Separating, tracking and recording of the lot numbers of pharmaceutical products was a new and important requirement that was previously not followed as stringently and was performed on a per case basis. This is important if there is a manufacturing abnormality or irregularity, preventing bilateral complications of TASS. Additionally, in the unfortunate circumstance patients developed TASS at once particular location, offending agents may be quickly identified. It should be noted that the process of separating, preparing and recording products via lot number by nursing staff prior to the day of surgery adds approximately 15 minutes per eye. We have suggested creating Right and Left Shelves for supplies for easy access and rapid availability. The use of intracameral antibiotics (specifically Moxifloxacin) was discussed and strongly recommended in all cases of ISBCS. 

Limitations of the protocol included: only allowing a maximum of five bilateral cases per day as a trial period, increased turn over time between patients due to COVID-19 cleaning, increased time due to hospital related screening protocols and availability of staff due to COVID-19 isolation Pre-intervention, the average number of cataract extraction cases completed per surgeon per day was approximately 21 cases prior to the COVID-19 pandemic. Each surgical day length was roughly 9 hours.

Post-intervention, October 2020, the number of cases completed was limited to 15 cases per surgeon per day. Each day was of the same duration (9 hours). However, of those 15 cases, each surgeon completed 5-6 bilateral cases per day which yielded a total of 20-21 eyes per surgeon per surgical day. Operating at this volume of bilateral cataracts brought the daily cataract volume per surgeon to be greater than 90%. There were a total of 406 cases that employed the adapted guidelines and zero TASS or endophthalmitis reported by the retina team. Sequence of eyes operated on: The same sequence can be performed for all ISBCS patients where first the left eye is operated on followed by the right. In this manner the same flow is observed. 4.

The second lens does not enter the room until the turn-over time.

Any difficulty with the first eye, the team should be ready to pause and postpone the surgery for the second eye 6.

Intracameral fluoroquinolones are recommended to be used for all ISBCS as per ISBCS society. The surgeon can choose to hold this in case of contraindications. 7.

Fluids: All lot numbers of fluids used in each eye should have a different lot number than the ones used for the second eye including tetracaine, Balanced Salt Solution bottles, phacoemulsification bags, Ophthalmic Viscosurgical Devices, and lidocaine. The same iodine preparation lot number may be used. 8.

Two batches of "extras" need to be marked as Right/Left, and present in the room for potential phenyl, vision blue or any other liquid consumables.

* After implementation, it was determined that very rarely are the same "extras" needed for both eyes.

Postoperative patient care will be surgeon specific. Recommendations include eye protection (glasses or shield) to be used immediately after surgery during daytime hours and tape-on shields for the first 5 to 7 nights. Drop regimen should follow that of DSBCS: topical 4 th generation fluoroquinolone, steroid and consideration of non-steroidal anti-inflammatory; ISBCS members recommend moxifloxacin 6 times a day for 3 to 4 days then 4-5 times a day for 5 days. [21] [22] Patients are also recommended to get a different set of bottles for each eye. Eyes should not be patched to allow prompt start of post-operative drops early after surgery. Patients are closely followed for signs of endophthalmitis and TASS. We also recommend informing triage teams to allow ISBCS patients to be seen with a lower threshold of symptoms. In Alberta, this would include Health-Link, a 24/7 call line where Albertan's can seek advice from a registered nurse pertaining to any immediate health concern. Finally, all complications should be tracked and incidents of TASS reported to the COS TASS task force. Having enough time to organize the cases -Book bilaterals after the fourth case and book two in a row at a time.

Constant change of medical availability in different lot numbers and communicating these to the nursing staff -Management is buying us a whiteboard to communicate updates and will be kept with the bilateral supplies. Table 4 is an example of organized communication occurring at our institution between multidisciplinary teams. All staff members were informed of the change and encouraged to prospectively report adverse events, process impacts and to offer comments and suggestions regarding the initiative. Any required adjustments were made by the study team and communicated to all staff.

A total of 406 patients underwent ISBCS between July 2020 to December 2020. In spite of the addition of preparatory steps and time to accommodate ISBCS we found incorporating ISBCS increased surgical volume by up to 25% compared to DSBCS alone. Since the beginning of the pandemic, surgical slates have slowly approached 75% of previous capacity, and with the addition of ISBCS, surpassing 90%. There are undeniable benefits to patients and also from a medical education perspective. It should also be noted that our institution set a "maximum" number of ISBCS that were allowed to be completed per surgeon on any given day, which was four during the initial rollout. We believe that there may be potential to increase surgical volume further if more bilateral cases were permitted.

Patient risks for ISBCS have been well described in the literature. To our knowledge, bilateral postoperative endophthalmitis (POE) has been reported in six cases in the literature (Table 5) . [18] [19] [20] [21] [22] [23] It should be noted however, that these cases did not follow guidelines that are now established by the International Society of Bilateral Cataract Surgeons. Dr. Steve Arshinoff, a world leader in ISBCS with over 12,000 cases, has zero cases of bilateral POE while following the iSBCS guidelines. Arshinoff and Bastianelli also reviewed similar practices and found zero cases of bilateral POE in 95,606 cases. 8 Vision group Canada (Cataract MD) reports 31,047 cases of ISBCS with zero cases of bilateral POE or TASS. Kaiser Permanente reported 1 unilateral POE in 5 247 ISBCS procedures (10 494 eyes) and 2 unilateral POE in 38 736 eyes DSBCS. The reported risk of unilateral POE following ISBCS following the iSBCS guidelines, including intracameral antibiotics at the end of surgery is 1 in 14 352 to 16 800 (0.006 to 0.007%) by the iSBCS group and 1 in 10 494 by the Kaiser Permanente Group. 12, 16 Our group in Edmonton strongly recommends and has adopted the use of intracameral antibiotics in ISBCS. We did not have any reported cases of endophthalmitis. Toxic Anterior Segment syndrome (TASS) is a rare and devastating complication of intraocular surgery that is defined as an acute sterile anterior chamber inflammatory reaction that usually develops within days after anterior segment surgery. To our knowledge, there have been no cases of bilateral TASS following ISBCS that have been reported in the literature. In the rare event of multiple TASS complications occurring at one institution, the strict guidelines of the iSBCS 2009 are meant to minimize the risk of TASS in both eyes. 16 We did not have any cases of TASS with the implementation of ISBCS.

A refractive surprise has been a potential concern for some ophthalmologists considering ISBCS. Some cataract surgeons feel more comfortable with delayed sequential bilateral cataract surgery, so the refractive outcome of the first eye may be utilized to assist with the surgical planning of the contralateral eye. However, Guber et al. retrospectively evaluated 110 sequential ISBCS to which refraction was within ±1.0D of the target in 83% of eyes. 24 Only 5% of cases (n=6) would have benefitted from DSBCS, potentially altering IOL choice. The Kaiser Permanente group reported postoperative spherical equivalent within 0.5D in 61% of patients OU in 13,711 DSBCS and 63% of patients OU in 3561 ISBCS. 12 With newer imaging modalities and formulas, the refractive measurements of the second eye are very well tolerated by most patients.

Post-operative macular edema and corneal decompensation may occur more than four weeks after surgery and would not be identified prior to surgery of the second eye in DSBCS. CME and corneal edema are treatable either by drops, injections or surgery. Careful selection of patients for ISBCS minimizes these risks.

It should be noted that conversion to DSBCS can be attributed to a number of factors including central endothelial damage, posterior capsular rupture, zonular instability, vitreous prolapse and others. Kaiser Permanente reported a conversion rate to DSBCS of 0.7% 12 . It is imperative that all patients interested in ISBCS be counselled on the possibility of conversion to DSCBS preoperatively.

There are a number of benefits in performing ISBCS, particularly during this pandemic. There is a 50% decrease in the number of hospital, clinic and pharmacy visits pertaining to the operating day and post-operative visits due to one less visit. ISBCS may also be ideal for anxious patients, as there is only one surgery rather than having to think about two separate surgeries. Additionally, respecting physical distancing policies, there is a 50% decrease in the number of close contact interactions with perioperative caregivers. There is also faster visual recovery and patients are able obtain spectacle adjustment sooner. Quicker restoration of binocular vision and stereopsis would allow patients to return to driving sooner and also reduce the risk of falls. Patients would likely find there is reduced discomfort and morbidity between surgeries, particularly in patients with high levels of anisometropia. Since both eyes are completed on the same day, there is likely a decreased risk of confusion in drop regimen between the two eyes. Furthermore, patients and caregivers would have less time off work and decreased transportation costs while decreasing the length and burden of care on the caregiver.

There are numerous benefits of ISBCS to the healthcare system including decreased waitlists for surgeries and decreased hospital costs. Hospital and office administration only needs to schedule one day per patient rather than two days and there is a decreased risk of patient identification errors. This is a 50% decrease in their scheduling per ISBCS patient. From a pandemic perspective, fewer patients require preoperative processing and preoperative and recovery areas are less crowded. Resources are better utilized as there is a decreased need for porters and stretchers and more efficient use of anaesthesiology time. In Canada, each ISBCS could significantly reduce the average hospital costs by 34%, with savings of approximately $500 compared with DSBCS. 7 After approval of ISBCS at our institution the nursing staff were advised of the changes in their morning "huddle". ISBCS was not a completely new concept to the team as this was occasionally performed in extenuating circumstances (Ex. Patients with cognitive impairment requiring a general anesthetic). Typically, five nursing team members are assigned to two operating rooms. However, due to the increased time required for documentation and preparation, a sixth nursing staff member was added to these rooms. Secondly, we received feedback from our nursing team that flow could be improved and opportunities for error reduced if all ISBCS were performed in sequence.

Residents and fellows can still be involved in ISBCS based on patient consent, resident skill level, and complexity of the cases. In fact, resident involvement and teaching may also be improved with ISBCS. By observing the surgery on the first eye, the resident may be better equipped to immediately use that surgical experience to help guide surgical steps on the contralateral eye, as both eyes may behave similarly in the same patient.

A multidisciplinary team was paramount in moving this initiative forward, all with a clear goal of safely improving patient care during a widespread pandemic. This initiative continues to be a work in progress, with a goal in improving specific steps of this initiative as seen in table 4. Broad principles that provide guidance for planning improvements include the use of a multidisciplinary team. Additionally, a critical component during this process was the importance of receiving constructive feedback through all stages of development and implementation. This was complemented by keen and receptive team members that were constantly making changes to streamline and improve patient care. Elective surgery in Canada has drastically decreased, resulting in markedly increased waitlists due to the COVID-19 pandemic response. When performed under the proper guidelines, ISBCS offers a low risk, cost effective solution to help decrease the backlogged surgical wait times. Using a multidisciplinary study team, the study group was able to institute the ISBCS initiative in the Edmonton area. Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Clearing the Backlog: The Cost to Return Wait Times to Pre-Pandemic Levels

Canadian Institute for Health Information. Benchmarks for treatment and wait time in Canada -Cataracts

Bilateral versus unilateral cataract extraction: advantages and complications

Immediately sequential versus delayed sequential bilateral cataract surgery: safety and effectiveness

Simulataneous bilateral versus sequential bilateral cataract surgery: Helsinki simultaneous bilateral cataract surgery study report

Benefit to patients of bilateral same-day cataract extraction: randomized clinical study

Immediately sequential bilateral cataract surgery versus delayed sequential bilateral cataract surgery: potential hospital cost savings

Incidence of post-operative endophthalmitis after immediate sequential bilateral cataract surgery

Simultaneous bilateral versus sequential bilateral cataract surgery: Helsinki Simultaneous Bilateral Cataract Surgery Study Report 1

Government of Spain publication. Seguridad, efectividad y coste efectividad de la cirugía de la cataratas bilateral y simula

Immediate sequential bilateral cataract surgery: surgeon preferences and concerns

Immediate Sequential versus Delayed Sequential Bilateral Cataract Surgery: Retrospective Comparison of Postoperative Visual Outcomes

Failure Modes and Effects Analysis of Bilateral Same-Day Cataract Surgery

Is bilateral, same-day cataract the future? Rev Ophthalmol

Immediately Sequential Bilateral Cataract Surgery (ISBCS): An Academic Teaching Center's Experience

International Society of Bilateral Cataract Surgeons. iSBCS General principles for excellence in ISBCS

Recommended practices for cleaning and sterilizing intraocular surgical instruments

Bilateral versus unilateral cataract extraction: advantages and complications

Bilateral endophthalmitis after simultaneous bilateral cataract surgery

Bilateral Pseudomonas aeruginosa endophthalmitis following bilateral simultaneous cataract surgery

Bilateral endophthalmitis after bilateral sequential phacoemulsification

Pseudomonas aeruginosa-induced bilateral endophthalmitis after bilateral simultaneous cataract surgery: case report

Bilateral Endophthalmitis after Immediately Sequential Bilateral Cataract Surgery. Ophthalmol Retina

Predictability of refraction following immediate sequential bilateral cataract surgery (ISBCS) performed under general anaesthesia

The Improvement Guide: A Practical Approach to Enhancing Organizational Performance

Evaluating the Quality of Medical Care